Trial Details

TERMINATED
Basic Information
Clinical ID c1065
Identifier NCT03943550
Trial Title Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Participants With Ulcerative Colitis (UC)
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Ulcerative Colitis
Interventions DRUG: RO7049665|DRUG: Placebo
Participant Information
Sponsor Hoffmann-La Roche
City Jacksonville
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE1
Time Information
Start Date 2019-05-13
Primary Completion Date 2021-07-22
Completion Date 2021-07-22